Sana Health, Inc., is developing a non-narcotic, non-addictive, wearable device to determine if it is effective in reducing symptoms of posttraumatic stress disorder (PTSD).
The Sana Device is an externally worn mask that physically contacts the skin of the face. It delivers Audio Visual Stimulation (AVS) in the form of coordinated pulses of light (through closed eyelids) and sound (through earphones) at targeted frequencies. It is meant to be worn at least twice per day at home.
Participants will be in one of two groups, randomly assigned like a flip of a coin. One group will receive VA Medical Center (VAMC) treatment as usual or treatment as usual plus use of the Sana device.
Participants will complete 3 virtual visits for assessments and four virtual check in visits.
This study is open to Veterans and military service members with a VA medical record seeking treatment for PTSD.
Patients with cardiovascular disease (CVD) are at increased risk of depression following hospital discharge. Unfortunately, most depressed CVD patients do not receive appropriate care for their depression, often because they are unable to, or are fearful of traveling to providers for the regimen of 8-12 weekly visits of therapy such as Behavioral Activation (BA). This study will compare the effectiveness of BA for depression, delivered via Telehealth, to standard post-CVD hospital discharge best practices. It is predicted that patients who receive BA will have better mental health outcomes and will be less likely to be re-hospitalized compared to patients who receive standard post-discharge care.
PTSD is a prevalent condition for which veterans frequently seek treatment in the VA healthcare system. There are a number of first-line PTSD treatment approaches available, such as Prolonged Exposure and Cognitive Processing Therapy. However, the efficacy rates of these treatments is not as high as what has been observed with civilian populations and approximately 36% of individuals drop out of these treatments prematurely. A proposed alternative to these treatments is Written Exposure Therapy (WET), a brief, 5 session intervention that has been shown to reduce symptoms of PTSD and contribute to lower dropout rates. The goal of this study is to investigate whether WET is as effective compared to Prolonged Exposure (PE) in the treatment of PTSD in a sample of veterans diagnosed with PTSD. It will involve approximately 150 Veterans. This research is funded by the Department of Veterans Affairs.